Personal Injury News

Medical Device Manufacturers Government Influence

The Food and Drug Administration rescinded approval of the Menaflex cow collagen knee implant, manufactured by ReGen Biologics Inc, representing the first time the FDA not only admitted political influence, but made a reversal without showing any evidence about a drug or device to make a decision. ReGen had attempted three times to get the go-ahead from the FDA, but failed each time. ReGen made appeals to a congressman from New Jersey to use their influence in order to gain market approval, using campaign contributions to encourage support.

The Manaflex was approved in December 2007, superseding regular reviews. Relationships such as these between politicians, medical device manufacturers and pharmaceutical companies don’t represent a new trend. One example of this relationship involves Attorney General Ashcroft of the Bush Administration.

In February 2008, Ashcroft secured a contract for his company worth $28-52 million. He oversaw Zimmer Holdings’ activities. Zimmer, a medical supply company that manufacturers hip and knee implants, underwent criminal charges for allegedly paying doctors to promote their products in patients.

As a hip recall attorney, it would be preposterous to consider that Ashcroft did not receive a contract from his consulting firm by accident. Zimmer paid the fee for oversight, making it less effective. In effect, the company that was charged with paying doctors to promote their products also paid its own oversight, who was able to get the job through political connections.

The Nagelberg Bernard Law Group is filing DePuy hip recall lawsuits on behalf of hip implant recall victims nationwide. Call our attorneys for a free and confidential DePuy ASR hip replacement recall consultation.

Comments are closed.